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I In nt tr ro od du uc ct ti io on n
The Genetics and Genomics of Infectious Diseases con-
ference (http://www.nature.com/natureconferences/ggid2009/
index.html) gathered researchers from diverse areas of
expertise to further our understanding of infectious diseases,
integrating knowledge of different aspects of pathogen and
host biology to form a holistic picture. It was the first time
that two major genetic societies, the American Society of
Human Genetics and the Human Genome Organisation,
have collaborated to bring together scientists interested in
different but interdependent aspects of infectious diseases.
The conference was also co-hosted by the Nature Publishing
Group, with support from the World Health Organization
and the Ministry of Health of Singapore. The meeting
attracted more than 250 participants, and around 30 talks
and over 40 posters were presented, with four workshops
given by biotechnology companies.
The meeting was able to integrate the diverse fields of
human responses to infectious disease, microbe discovery,
epidemiology, drug discovery and others by focusing on
high-throughput genomic technologies. It was remarkable
how this provided a common language to all the participants
and allowed deep understanding of areas outside each
individual’s usual expertise.
Some of the more novel insights came from the direct
application of these technologies by groups that might not
see themselves as traditional microbiologists. For example,
Rotem Sorek (Weizmann Institute of Science, Rehovot,
Israel) described a novel method of antimicrobial discovery,
following their realization that cloning gaps in microbial
sequencing undertakings may be due to genes that kill the
cloning microorganism, Escherichia coli. It was fascinating
to hear the innovative perspective given to a common
phenomenon that is not given much attention in sequencing
and that could potentially be turned to high-throughput
screening for antimicrobials through microfluidics. Daniel
Falush (University College, Dublin, Ireland) also gave an
absorbing talk about using new-generation genomic tech-
nology and analytical methods such as sloppy painting (a
novel approach for understanding patterns of admixture
between populations) to describe gene flow in Helicobacter
pylori in detail, revealing that their migration across conti-
nents is tied to that of humans, and thus where their
selective pressures come from - fascinating insights into ‘the
private lives of bacteria’.
There was also a glimpse of the future of how the genomics
approach might be applied more systematically to infectious
diseases from Ulf Nehrbass (Institute Pasteur, Seoul, Korea).
His group established high-content screening, which enables
live visualization together with evaluation of the infection
process, within high level bio-safety containment. Such
methodologies are more typically used by companies, but
this approach was shown to give biological insights andmechanisms, as well as to identify antimicrobial drugs and
their targets.
A unique feature of the conference was a discussion session
on how advanced genomic sciences can be integrated into
the framework of public health and government policies to
combat infectious diseases. With the rapid development of
our understanding resulting from these approaches, imple-
mentation is going to be crucial, and several contributors
made insightful remarks. However, it was the scene-setting
talk from Tikki Pang (World Health Organization, Geneva,
Switzerland) that captured the imagination. He reminded all
present about how much work was required, as existing
drugs are becoming less effective (with few new ones on the
horizon) and new infectious agents are arriving constantly -
usually from those areas of the world with the least surveil-
lance. In particular, diagnostics need to be better, cheaper
and preferably in the hands of the doctors in primary health
care settings. Another contributor in this session, Edison Liu
(President of the Human Genome Organisation and
Executive Director of the Genome Institute of Singapore),
provided some possible solutions, highlighting that as
microbiology, through genetic high-throughput technolo-
gies, is becoming an information science, sharing databases
of information will become easier. Networks of countries
and scientists could develop, and Liu pointed to the
company Google, which has attempted to monitor infectious
disease outbreaks using its internet-based system of
information collation. Several overarching themes covered
during the conference are discussed in more detail below.
V Vi ir ru us s   e ep pi id de em mi io ol lo og gy y   a an nd d   e ev vo ol lu ut ti io on n
The microbiology field has been transformed by the ready
availability of high-throughput sequencing, with influenza
taken as a case study by many speakers. Edward C Holmes
(Pennsylvania State University, University Park and the
National Institutes of Health, Bethesda, USA) described
several aspects, including the spatial and temporal dynamics
of influenza (pointing out the difference between genetic and
antigenic space), molecular viral evolution from a genomics
viewpoint, and possible origins of amantadine-resistant
strains. A striking realization from this was that new
influenza strains arrive in the USA each year from South
East Asia, rather than developing within the country.
Sunetra Gupta (University of Oxford, UK), proposed an
explanation for the rise of influenza pandemics, in which
selection by the host immune system has a crucial role in
determining pandemic influenza strains in a limited
antigenic space. The optimism for this description of how
new strains evolve was shared by Neil Ferguson (Imperial
College London, UK), as his work predicted a drastic
decrease in the spreading rate of drug-resistant strains as a
result of highly stratified host population structures. Malik
Peiris (University of Hong Kong, Hong Kong) also high-
lighted the need to re-examine the role of the host response
in high-pathogenicity influenza strains and cautiously
explored the possibility of using immunomodulation for
therapy. It is likely that further research using cutting edge
technology will continue to shed light and overturn widely
held dogmas in this field.
R Ro ol le e   o of f   i in nd di ig ge en no ou us s   m mi ic cr ro of fl lo or ra a
Another fast-moving field is the expanding research on gut
microbiota, with speakers strongly putting forth the idea of
the human as a ‘superorganism’, with indigenous microbiota
having a complex and deep relationship with human biology.
One of the highlights was delivered by Jacques Ravel
(University of Maryland, College Park, USA), who proposed
the idea that it is resilience that determines the composition
of microbial communities, rather than a core microbiome as
was the widely held opinion. Ravel’s idea is strengthened by
microbial survey data from human vaginal bacterial
communities from women across different ethnic groups.
The importance of indigenous microbiota was further
reinforced by Martin J Blaser (New York University Langone
Medical Center, New York, USA), whose work covered the
delicate balance between H. pylori and human physiology,
with a decreased prevalence possibly linked to gastro-
esophageal disease and hormonal imbalances related to
energy homeostasis. He suggested the ‘disappearing micro-
biota’ hypothesis (not to be confused with the hygiene hypo-
thesis), in which dramatic changes in indigenous microbiota
transmission and maintenance cause equally dramatic
changes in human physiology. The research presented raised
as many questions as it answered, and it would be
interesting to see future research strengthening or altering
the various hypotheses put forth or even forming relation-
ships in unexpected ways.
T Th he e   g ge en ne et ti ic cs s   o of f   t th he e   h ho os st t   r re es sp po on ns se e
The human genetics field has been revolutionized by the
recent introduction of the genome-wide association study
(GWAS) approach. The infectious disease field has been
applying this to a range of diseases, with GWAS covering
tuberculosis (Fredrik Vannberg, Oxford University, Oxford,
UK), human immunodeficiency virus (HIV; Stephen J
O’Brien, National Cancer Institute, Rockville, USA), dengue
(Cameron Simmons, Oxford University, Ho Chi Minh City,
Vietnam), malaria (Yik Y Teo, Oxford University, Oxford and
Cambridge University, Cambridge, UK) and leprosy
(Laurent Abel, University Paris Descarte, Paris, France)
presented at the meeting. Although this was certainly the
cutting edge of the field, overall the presentations were
perhaps more preliminary in the analysis stages, with many
of the talks focusing on a discussion of methodological
issues. A particularly detailed methodology came from
O’Brien, who revealed a process for combining multiple
analyses, both statistically and phenotypically, to obtain
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discussed the difficulties of using the standard GWAS
approach in African populations, as the linkage dis-
equilibrium structure is far more complex than in out-of-
Africa populations. However, if associations are found,
African populations may be very helpful in narrowing down
causal variants. He also highlighted the difficulties of
identifying rare causal variants, using the sickle cell
mutation as an example.
C Co on nc cl lu us si io on ns s
This highly invigorating and thought-provoking conference
succeeded through a combination of excellent, first-rate
speakers who are leaders in their fields, a highly focused
theme (understanding host-pathogen interactions) tackled
from the wide perspectives of human and pathogen
genomes, and active discussion of the impact the work might
have on those most affected by infectious disease. It would
be exciting to hold another similar meeting for this fast-
moving area in the near future.
A Ab bb br re ev vi ia at ti io on ns s
GWAS, genome-wide association study.
A Ac ck kn no ow wl le ed dg ge em me en nt ts s
We thank all the speakers who presented their research during the
meeting.
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